3 days AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in EuropeZacks
The European Commission approves ABBV’s Elahere for the treatment of platinum-resistant ovarian cancer.
XThe European Commission approves ABBV’s Elahere for the treatment of platinum-resistant ovarian cancer.
X